Overall, these results may provide hints that CHM1 may balance a certain level of chondro‐osseous differentiation capability and supports stronger CHM1 expression in lung metastases compared to bone samples of patients with ES, as observed here. This evidence concerns the gene CNMD and Ewing sarcoma.